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Glucocorticoids have been shown to modulate the expression of noradrenaline metabolizing
enzymes and β2- and α1B-adrenoceptors in a tissue- and cell- specific manner. In the thymus,
apart from extensive sympathetic innervation, a regulatory network has been identified that
encompasses catecholamine-containing non-lymphoid and lymphoid cells. We examined a
putative role of adrenal- and thymus-derived glucocorticoids in modulation of rat thymic
noradrenaline levels and adrenoceptor expression. Seven days postadrenalectomy, the thymic
levels ofmRNAs encoding tyrosine hydroxylase, dopamine β-hydroxylase, monoamine oxidase-
A and, consequently, noradrenaline were decreased. Catecholamine content was diminished
in autofluorescent nerve fibres (judging by the intensity of fluorescence) and thymocytes
(considering HPLCmeasurements of noradrenaline and the frequency of tyrosine hydroxylase-
positive cells), while it remained unaltered in non-lymphoid autofluorescent cells. In addition,
adrenalectomy diminished the thymocyte expression of β2- and α1B-adrenoceptors at both
mRNA and protein levels. Administration of ketoconazole (an inhibitor of glucocorticoid
synthesis/action; 25mg kg−1 day−1, s.c.) to glucocorticoid-deprived rats increased the thymic
levels of tyrosine hydroxylase, dopamine β-hydroxylase and, consequently, noradrenaline.
The increased intensity of the autofluorescent cell fluorescence in ketoconazole-treated rats
indicated an increase in their catecholamine content, and suggested differential glucocorticoid-
mediated regulationof catecholamines in thymic lymphoid andnon-lymphoid cells. In addition,
ketoconazole increased the thymocyte expression of α1B-adrenoceptors. Thus, this study
indicates that in the thymus, as in someother tissues, glucocorticoids not only act in concertwith
cateholamines, but they may modulate catecholamine action by tuning thymic catecholamine
metabolism and adrenoceptor expression in a cell-specific manner. Additionally, the study
indicates a role of thymus-derived glucocorticoids in this modulation.
(Received 1 February 2012; accepted after revision 3 May 2012; first published online 4 May 2012)
Corresponding author G. Leposavic´: Department of Physiology, Faculty of Pharmacy, University of Belgrade, 450
Vojvode Stepe, 11221 Belgrade, Serbia. Email: gordana.leposavic@pharmacy.bg.ac.rs
The thymus is the primary lymphoid organ required
for the development of immunocompetent T cells and
the establishment of an efficient immune response.
Development of T cells is modulated by many extrinsic
factors, directed by the CNS. The brain delivers
information to the thymus by twomajor channels, namely
the hypothalamic–pituitary–adrenal axis hormones and
sympathetic fibres of the autonomic nervous system
(Weigent & Blalock, 1997). Although the sympathetic
nerve fibres are the main source of catecholamines
(CAs) in rodent thymus (Felten et al. 1985; Leposavic´
et al. 1992; Elenkov et al. 2000), their synthesis in
thymocytes and thymic non-lymphoid cells has also been
demonstrated (Pilipovic´ et al. 2008).Moreover, it has been
shown that CAs, acting on thymic lymphoid and non-
lymphoid cell β2- and α1B-adrenoceptors (ARs) provide
fine-tuning of thymocyte differentiation/maturation and,
consequently, the maintenance of the peripheral T-cell
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repertoire and self-tolerance (reviewed by Leposavic´ et al.
2011). Additionally, CAs released from thymic cells are
also supposed to act as immunotransmitters, transferring
information to nerve fibre endings (reviewed by Leposavic´
et al. 2011).
When stability of the internal milieu is disturbed or
threatened by internal or external challenges, both the
sympathetic nervous systemandhypothalamic–pituitary–
adrenal axis become activated, resulting in increased
circulating levels of CAs and glucocorticoids (GCs). They
act in concert to maintain the steady state of the internal
milieu (Chrousos & Gold, 1992). In addition, GCs have
been shown to influence bioavailability of CAs in the
tissues by modulating the expression of enzymes involved
in CA biosynthesis and degradation in a tissue- and cell-
type-specific manner (Lucas & Thoenen, 1977; McMahon
& Sabban, 1992; Hiwatashi et al. 2002; Kano et al. 2005;
Lindley et al. 2005; Kvetnansky et al. 2009). Moreover,
GCs influence β- and α1-AR gene expression in a tissue-
and cell-type-specific manner (Davies & Lefkowitz, 1980;
Kavelaars, 2002; Abraham et al. 2003).
Thymocytes (Wiegers et al. 2001; Boldizsar et al. 2010),
thymic epithelial cells (TECs) and dendritic cells express
the classical cytosol glucocorticoid receptor (GR; Sacedo´n
et al. 1999; Talaber et al. 2011). In addition, local GC
synthesis has been found in thymocytes and TECs (Qiao
et al. 2009; Taves et al. 2011), as in some other cell types
(Cima et al. 2004). The thymic GC synthesis is influenced
by the circulating GC level in a cell-type-specific manner
(Qiao et al. 2009; Taves et al. 2011). Glucocorticoids in the
thymus act as important regulators of thymocyte survival
and differentiation (Ashwell et al. 1996; Chung et al. 2002;
Stojic´-Vukanic´ et al. 2009).
Considering all the aforementioned information, itmay
be supposed that GCs modulate CA-mediated tuning
of thymopoiesis by influencing neural and/or non-
neural thymic CA synthesis and/or AR expression. This
hypothesis is supported by a study showing that the effects
of β-AR blockade on thymopoiesis differ substantially
between adrenalectomized (Adx) and control non-Adx
rats (Pilipovic´ et al. 2010).
To further confirm this hypothesis in thymi and
thymocytes from Adx rats, in the present study we
measured the following parameters: (i) noradrenaline
(NA) level; (ii) the expression of mRNAs encoding major
enzymes involved in NA metabolism; (iii) the density of
CA-containing autofluorescent nerve fibres and cells and
the intensity of their fluorescence; and (iv) the expression
of β2- and α1B-ARs at both the mRNA and the protein
level. To elucidate the putative influence of intrathymically
synthesized GCs on thymic NA bioavailability and
AR expression, we examined the same thymic and
thymocyte parameters in adrenalGC-deprived rats treated
with ketoconazole (KET), a steroid hormone synthesis
blocker and GC receptor antagonist (Loose et al. 1983;
Deuschle et al. 2003). To exclude possible effects of KET-
induced testicular steroid deprivation on these parameters
(Pilipovic´ et al. 2008; Leposavic´ et al. 2011), the rats treated
with KET were bilaterally orchidectomized.
Methods
Ethical approval
The animals used in this studywere handled in accordance
with Directive 2010/63/EU of the European Parliament
and of the Council on the protection of animals used
for scientific purposes (revising Directive 86/609/EEC),
and the experimental protocol was approved by the
Experimental Animal Committee of the Immunology
Research Centre ‘Branislav Jankovic´’.
Experimental design
Two sets of experiments were performed using male 75-
day-old Dark Agouti rats (n= 74).
In the first experiment, rats were subjected to bilateral
adrenalectomy via a single dorsal incision under general
anaesthesia. The anaesthetic solution (0.8 ml (100 g body
weight)−1, I.P.) consisted of ketamine (100mgml−1;
Ketamidor
R©
; Richter PharmaAG,Wels, Austria), xylazine
(20mgml−1; Xylased R©; Bioveta, Ivanovice na Hane´,
Czech Republic) and saline, in a 1:0.5:8.5 ratio. Control
rats were sham adrenalectomized using the same surgical
procedure, but without removal of the adrenals. Both
Adx and sham-Adx animals were provided with 0.9%
saline in drinking water. Completeness of adrenalectomy
was confirmed by histological examination of removed
tissue, checking for residual adrenal tissue at post-mortem
examination, and measuring the blood corticosterone
concentration.
In the second experiment, following adrenalectomy the
rats were bilaterally orchidectomized through a transverse
scrotal incision. From the following day, the rats were
subcutaneously administered with 25mg kg−1 day−1 KET
(Sigma-Aldrich Chemie Gmbh, Tufkirchen, Germany).
Animals administered with vehicle (polyethylene glycol;
PEG) served as controls.
In both sets of experiments, 7 days postsurgery the rats
were killed by exposure to an increasing concentration of
CO2, followed by exsanguination. Each group consisted of
six animals.
Chemicals, antibodies and immunoconjugates
Tween 20 and L-noradrenaline hydrochloride were
purchased from Sigma-Aldrich Chemie Gmbh. Target
Retrieval Solution and LSAB+ Systemwere obtained from
DakoCytomation (Glostrup, Denmark). Gene Expression
Master Mix and commercial TaqMan Gene Expression
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Assays for rat tyrosine hydroxylase (TH; Rn00562500
m1), dopamine β-hydroxylase (DBH; Rn00565819 m1),
phenylethanolamine N-methyltransferase (PNMT;
Rn01495588 m1), monoamine oxidase-A (MAO-A;
Rn01430950 m1), β2-AR (Rn00560650 s1), α1B-
AR (Rn01471343 m1) and hypoxanthine guanine
phosphoribosyltransferase 1 (HPRT1; Rn01527840 m1)
were obtained from Applied Biosystems (Foster City, CA,
USA).
Monoclonal antibody specific to TH (clone TOH
A1) were purchased from BD Biosciences Pharmingen
(San Jose, CA, USA), polyclonal rabbit anti-β2-
AR and polyclonal goat anti-α1B-AR antibodies were
purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Second-step reagents were obtained
from BD Biosciences Pharmingen (goat anti-mouse
IgG fluorescein isothiocyanate, goat anti-rabbit IgG
fluorescein isothiocyanate) and Sigma-Aldrich Chemie
Gmbh (rabbit anti-goat IgG fluorescein isothiocyanate).
Measurement of CAs by HPLC
Briefly, one lobe of each thymus was frozen at −70◦C
for whole thymic tissue CA analyses, while the other
was passed through a stainless-steel mesh into ice-
cold PBS to obtain a thymocyte suspension. The
thymocyte suspension (1× 108 cells) was centrifuged at
250g and the pellet resuspended in 200μl of cold
0.1 M perchloric acid solution containing 0.15% Na2S2O5
and 0.05% Na2EDTA (HPLC solution) and stored at
−70◦C until analysis. Before analysis, the thymic tissue
homogenized in 0.4 ml of HPLC solution and thawed
thymocyte suspensions were centrifuged at 30,000g for
20min. The analytical system consisted of a Waters
high-performance liquid chromatograph (E600 pump;
Waters Corp., Milford, MA, USA) with an autosampler
(Waters 717 Plus) and detector (GBC amperometric ECD
1260) and a Chromsystems column for Catecholamines
(p/n 6100, 150mm; Chromsystems Instruments &
Chemicals GmbH, Gra¨felfing/Mu¨nchen, Germany). A
mobile phase of Chromsystems Mobile phase for
Catecholamines (p/n 5001) was used. All separations
were performed at flow rate of 1 ml min−1. The detector
potential was maintained at+0.65 V. The electrochemical
detector sensitivity for thymic and thymocyte samples was
2 and 1 nA, respectively. For the quantification of NA
content, the software Empower CS (Empower Masterpay
Pty Ltd, Kent Town, SA, Australia) was used.
Fluorescence histochemistry
To visualize CA-containing nerve fibres and cells, serial
20-μm-thick thymic cryosections were treated by a
modification of the sucrose phosphate–glyoxylic acid
method (Radojevic´ et al. 2011). Briefly, the slides were
dipped in a solution containing 1% glyoxylic acid, 0.2 M
sucrose and 0.236 M KH2PO4 (pH 7.4), drained, covered
with non-autofluorescent immersion oil and heated at
95◦C for 2.5 min, and then coverslipped. The sections
were photographed on the same day using an Olympus
BH 2 fluorescence photomicroscope (Olympus Optical
Co., Ltd, Tokyo, Japan) and digital camera (Color View III;
Olympus Soft Imaging Solutions, Mu¨nster, Germany)
and AnalySIS FIVE software (Olympus Soft Imaging
Solutions). For digital quantification of fluorescence
intensity and density, 15 test areas selected at random
from five sections of each thymus were captured.
The digital outline of each autofluorescent profile/large
autofluorescent cell was traced, and the fluorescence
intensities were measured digitally using ImageJ software,
yieldingvaluesofpixel intensityperunit area, aspreviously
described (Radojevic´ et al. 2011). Fluorescent nerve fibre
density was measured using a stereological grid point-
counting approach and expressed as the percentage of field
area occupied by the fluorescent nerve profiles (Radojevic´
et al. 2011). Large autofluorescent cell density was counted
using a 0.027mm2 quadrant lattice by an observer with no
previous knowledge of which slide was being analysed.
Immunofluorescence staining and flow cytometric
analysis
A single-cell suspension was obtained by grinding the
thymic tissue on a 60μm sieve screen submerged in ice-
cold PBS containing 0.09% NaN3 and 2% fetal calf serum
(FACSbuffer),washed andenumeratedusing an improved
Neubauer haemocytometer.
For analysis of TH and β2-AR expression,
1× 106 thymocytes were fixed (30min) with 0.25%
paraformadehyde (Sigma-Aldrich Chemie Gmbh) in
PBS at 4◦C, permeabilized with PBS containing 0.2%
Tween 20 and 0.09% NaN3 for 15min at 4◦C and
washed twice in ice-cold washing solution. Permeabilized
and non-permeabilized cells (for α1B-AR expression
analysis) were incubated with primary antibody. After
incubation (30min, 4◦C) cells were washed twice,
and appropriate secondary fluorescein isothiocyanate-
conjugated antibody was added. Following incubation
and washing, the cells were analysed on FACScan (Becton
Dickinson Immunocytometry Systems, San Jose, CA,
USA) using CellQuest software (Becton Dickinson
Immunocytometry Systems).
Immunocytochemical staining and quantification
To identify the cells expressing TH, β2- and α1B-ARs,
thymic tissue was fixed in IHC Zinc fixative (BD
Biosciences Pharmingen), embedded in paraffin and cut
into 5-μm-thick serial sections. These sections were
subjected to heat-induced epitope retrieval in Target
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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retrieval solution. The staining procedure was performed
using LSAB+ System according to the manufacturer’s
manual. Anti-rat TH (1:200 dilution), β2-AR (1:40
dilution) and α1B-AR (1:100 dilution) were used as
primary antibodies. Upon completion of the reaction,
thymic sections were counterstained with Haematoxylin
and analysed using an Olympus BH 2 microscope
equipped with a digital colour camera (Color View III;
Olympus Soft Imaging Solutions). Approximately every
40th section was subjected to stereological measurements
of immunoreactive (ir) cell numerical density (Nv;
number of cells per tissue volume unit) by the point and
intersection counting method (Karapetrovic et al. 1995)
using the AnalySIS FIVE software.
Quantification of mRNA using quantitative PCR
Total RNA was isolated from freshly harvested thymic
tissue and thymocytes, using ABI Prism 6100 Nucleic
Acid PrepStation (Applied Biosystems) and Total RNA
Chemistry (Applied Biosystems). Reverse transcription
was performed with the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems), and 5μl cDNA
was used for real-time PCR. Triplicate 25μl reactions
were run in Applied Biosystems 7500 universal cycling
conditions. All procedures were performed according
to manufacturer’s manuals. Hypoxanthine guanine
phosphoribosyltransferase 1 was selected as the internal
standard, to normalize for input cDNAvariations, because
it displayed an optimal stability among various samples
tested. Quantitative differences in gene expression levels
were assessed using Applied Biosystems SDS software
(version 1.4.0.) and the 2−Ct method.
Statistical analysis
All data are presented as means± SEM. To determine the
significance of differences between groups, depending on
the F test for unequal variance, Student’s unpaired t test
was applied without or withWelch’s correction. Statistical
analysis of thequantitativePCRCt valueswasperformed
using the Mann–Whitney rank sum test. All analyses were
performed with GraphPad Prism 5 software (GraphPad
Software, Inc., La Jolla, CA, USA), with the significance
level set at P < 0.05.
Results
Effect of surgical removal of circulatory adrenal
hormones on thymic CA-containing nerve fibres and
cells and AR expression in Adx and male Dark Agouti
rats
Thymic NA level and NA-synthesizing and -degrading
enzyme mRNA expression. In hypertrophic (P < 0.01)
thymi of Adx rats (Fig. 1Aa) the concentration of
NA was diminished (P < 0.05) compared with sham-
Adx control animals (Fig. 1Ab and Fig. S1). To
elucidate mechanisms underlying this decrease, the
thymic expression of mRNAs encoding enzymes involved
in NA biosynthesis and degradation was examined.
Adrenalectomy diminished (P < 0.05) the expression of
mRNAs for the following enzymes: (i) TH,which catalyses
the rate-limiting step in CA synthesis (conversion of
tyrosine to 3,4-dihydroxyphenylalanine); (ii) DBH, which
converts dopamine to NA; and (iii) MAO-A, which
catalyses monoamine oxidation. The amount of mRNA
encoding PNMT (which converts NA to adrenaline)
remained unaltered in Adx compared with sham-Adx rats
(Fig. 1Ac).
Fluorescence histochemistry and TH immunocyto-
chemistry. Toestimate the contributionofdistinct thymic
NA sources to changes in this neurotransmitter/hormone
concentration in the thymus, we analysed the density
of CA-containing nerve fibres and cells. Adrenalectomy
diminished (P < 0.05) the density of autofluorescent
nerve fibres and the intensity of their fluorescence (Fig.
2A); however, it did not affect either the density of
large autofluorescencent cells or the intensity of their
fluorescence (Fig. 2 A).
Furthermore, no difference was observed in either
Nv of TH-ir thymocytes or that of TH-ir thymic non-
lymphoid cells between Adx and control rats (Fig. 3B).
The unchanged Nv of TH-ir non-lymphoid cells, in
conjunction with the unaltered density of autofluorescent
cells and the intensity of their fluorescence (Fig. 2A),
suggested that adrenalectomy did not affect the
contribution of the non-lymphoid cellular compartment
to the overall thymic NA concentration.
Thymocyte NA content and expression of TH mRNA. To
estimate the putative contribution of the numerically
enriched (P < 0.01) thymocyte compartment (Fig. 4Aa)
to the decrease of thymic NA concentration in Adx
rats, the thymocyte NA content and expression of TH
were examined. Adrenalectomy diminished (by ∼44%;
P < 0.05) the NA content in thymocyte suspensions
(Fig. 4Ab andFig. S1). This decreasewasmorepronounced
than that (by ∼33%; P < 0.01) in the frequency of
tyrosine hydroxylase-positive (TH+) cells in the same
thymocyte suspensions (Fig. 4Ac and Fig. S2). Thus,
it may be assumed that adrenalectomy diminished the
amount of NA per thymocyte. Consistent with this view, a
corresponding decline (P < 0.05) was observed for mean
fluorescence intensity (MFI; reflecting decrease in the
protein density) ofTH(an enzymewith amajor regulatory
role in CA biosynthesis) in TH+ thymocytes from Adx
rats (Fig. 4Ad and Fig. S2). In addition, the TH mRNA
expression was also decreased (P < 0.05) in the thymocyte
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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suspensions from Adx rats (Fig. 4Ae). Given that this
decrease (by ∼47%) was also more pronounced than that
in the frequency of TH+ cells, a diminished expression
of TH mRNA per thymocyte in Adx rats was strongly
indicated.
Thymic and thymocyte expression of ARs.
Adrenalectomy decreased (P < 0.05) β2-AR mRNA
expression in thymic tissue (Fig. 5Bb). However,
treatment did not affect Nv of either β2-AR-ir
thymocytes or β2-AR-ir thymic non-lymphoid cells
(Fig. 5Ba).
Analysis of the β2-AR mRNA expression in thymocyte
suspensions showed that adrenalectomy downregulated
(P < 0.05) β2-AR mRNA expression (Fig. 5Be). This
finding, together with the increased (P < 0.05) frequency
of β2-AR-positive cells in thymocyte suspensions from
Adx compared with control rats (Fig. 5Bc), indicated
a decreased β2-AR mRNA expression per thymocyte.
In addition, the diminished (P < 0.05) β2-AR MFI
on β2-AR-positive thymocytes indicated a decrease
in the receptor surface density on thymocytes from
Adx compared with sham-Adx rats (Fig. 5Bd and
Fig. S2).
Adrenal gland ablation decreased (P < 0.05) α1B-AR
mRNA expression in thymic tissue (Fig. 6Bb). In thymi of
these rats, Nv of α1B-AR-ir thymic non-lymphoid cells was
substantially increased (P < 0.01), while that of α1B-AR-ir
thymocytes was unaltered when compared with control
animals (Fig. 6Ba).
Adrenalectomy reducedbothα1B-ARmRNAexpression
(P < 0.05; Fig. 6Be) in thymocyte suspensions and the
frequency of α1B-AR+ cells (P < 0.01; Fig. 6Bc). A
more pronounced adrenalectomy-induced decrease (by
∼67%) in the α1B-AR mRNA expression than that
in the frequency of α1B-AR-positive cells (by ∼30%;
P < 0.01) indicated the diminished α1B-AR mRNA
expression per thymocyte. Consistent with this view was
a corresponding decline (P < 0.01) in α1B-AR MFI on
α1B-AR-positive thymocytes from Adx rats (Fig. 6Bd and
Fig. S2).
Figure 1. Influence of adrenal- and thymus-derived glucocorticoids on thymic weight (a), thymic
noradrenaline (NA) concentration (b) and the mRNA expression of NA biosynthetic and metabolizing
enzymes (c) in thymi of adrenalectomized (Adx) and sham-Adx rats (A) and in Adx and orchidectomized
rats treated with ketoconazole (KET) and polyethylene glycol (PEG; B)
Abbreviations: DBH, dopamine β-hydroxylase; MAO-A, monoamine oxidase-A; PNMT, phenylethanolamine N-
methyltransferase; and TH, tyrosine hydroxylase. Results are expressed as means ± SEM (n = 6). ∗P < 0.05,
∗∗P < 0.01.
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Effect of inhibition by ketoconazole of thymic steroid
synthesis and action on thymic CA-containing nerve
fibres and cells and AR expression in Adx and
orchidectomized male Dark Agouti rats
Thymic NA level and NA-synthesizing and -degrading
enzyme mRNA expression. Inhibition of local GC
synthesis in Adx and orchidectomized rats by KET
reduced (P < 0.05) thymic weight (Fig. 1Ba). Compared
with vehicle-treated control animals, in KET-treated rats
the thymic NA concentration was increased (P < 0.05;
Fig 1Bb and Fig. S1). In addition, in these rats the thymic
expression of TH (P < 0.05) and DBHmRNAs (P < 0.05)
were augmented (Fig. 1Bc). The thymic expression of
Figure 2. Influence of adrenal- and thymus-derived glucocorticoids on the density of thymic
catecholamine-containing autofluorescent nerve fibres and cells and the intensity of their fluorescence
The photomicrographs show catecholamine-containing nerve profiles (arrows) and cells (arrowheads) visualized
using sucrose phosphate glyoxylic acid in the outer thymic cortex (a) and the deep cortex and medulla (b) of
adrenalectomized (Adx) and sham-Adx rats (A) and KET- and PEG-treated Adx and orchidectomized rats (B).
Original magnification ×400. Abbreviations: C, cortex; Ca, capsule; CMJ, cortico-medullary junction; and M,
medulla. Dashed white lines indicate thymic capsule-cortex borders. The histograms (c and d) represent the
density (c) of autofluorescent nerve profiles (left panels) and cells (right panels) and the normalized intensity of
their fluorescence (d) in Adx and sham-Adx rats (A) and in KET- and PEG-treated Adx and orchidectomized rats
(B). Results are expressed as means ± SEM (n = 6). ∗P < 0.05, ∗∗P < 0.01.
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PNMTandMAO-AmRNAs remainedunchanged inKET-
treated rats compared with control animals (Fig. 1Bc).
Fluorescence histochemistry and TH immunocyto-
chemistry. Ketoconazole increased (P < 0.05) the density
of thymic autofluorescent nerve fibres, without affecting
the intensity of their fluorescence (Fig. 2B). On the
contrary, KET did not affect fluorescent cell density, but
increased (P < 0.01) the intensity of their fluorescence
(Fig. 2B).
The immunocytochemical visualization of TH+ cells
demonstrated no difference inNv of TH-ir non-lymphoid
cells or TH-ir thymocytes between KET-treated rats and
control animals (Fig. 3C).
Thymocyte NA content and expression of TH mRNA.
ComparedwithPEG-treated control rats, KETdiminished
(P < 0.01) the total number of thymocytes (Fig. 4Ba),
as well as NA content (P < 0.05; Fig. 4Bb and
Fig. S1) and amount of TH mRNA (P < 0.05; Fig. 4Be),
in thymocyte suspensions. The unaltered frequency of
TH+ cells in thymocyte suspensions from KET-treated
rats compared with PEG-treated rats (Fig. 4Bc and
Fig. S2) suggested a decrease in the amount of NA
and TH mRNA per thymocyte. In addition, judging
by TH MFI, TH expression at protein level (Fig. 4Bd
and Fig. S2) was decreased (P < 0.05) in thymocyte
suspensions fromKET-treated rats comparedwith control
animals.
Thymic and thymocyte expression of ARs. The inhibition
of local GC synthesis did not affect thymic β2-AR mRNA
expression (Fig. 5Cb). In addition, Nv of both β2-AR-
ir thymic non-lymphoid cells and thymocytes remained
unaltered in KET-treated rats compared with PEG-treated
control animals (Fig. 5Ca).
The frequency of β2-AR-positive cells, the amount of
thymocyte β2-AR mRNA and β2-AR MFI on β2-AR-
positive thymocytes remained unaltered in thymocyte
suspensions from KET-treated rats compared with PEG-
treated control rats (Fig. 5Cc–e and Fig. S2).
In thymi from KET-treated rats, the α1B-AR mRNA
expression was almost twofold higher (P < 0.05) than in
thymi from vehicle-administered control animals (Fig.
6Cb); however, neither Nv of α1B-AR-ir thymic non-
lymphoid cells nor that of α1B-AR-ir thymocytes was
affected by KET administration (Fig. 6Ca).
Ketoconozole decreased (P < 0.05) the frequency of
α1B-AR-positive cells in thymocyte suspensions, but it
increased (P < 0.05) α1B-AR MFI on α1B-AR-positive
thymocytes (Fig. 6Cc and d andFig. S2). The decreased (by
∼30%) frequency of α1B-AR-positive cells in thymocyte
suspensions, coupled with the unaltered amount of α1B-
AR mRNA (Fig. 6Ce), suggested an increased α1B-AR
mRNA expression per thymocyte.
Figure 3. Influence of adrenal- and thymus-derived glucocorticoids on the density of thymic tyrosine
hydroxylase-positive (TH+) cells
A, representative photomicrograph shows TH-immunoreactive thymocytes (arrows) and non-lymphoid cells
(arrowheads) in thymus from sham-adrenalectomized (Adx) rats. Original magnification ×400. Abbreviations: C,
cortex; and M, medulla. Dashed black line indicates the cortico-medullary border. The histograms show numerical
density (Nv) of thymocytes, thymic non-lymphoid cells and all thymic cells expressing TH in thymi from Adx
and sham-Adx rats (B) and KET- and PEG-treated Adx and orchidectomized rats (C). Results are expressed as
means ± SEM (n = 6).
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Figure 4. Influence of adrenal- and thymus-derived
glucocorticoids on the overall number of thymocytes (a),
thymocyte noradrenaline (NA) content (b), the percentage of
TH+ cells (c), TH mean fluorescence intensity (MFI) on TH+
thymocytes (d) and TH mRNA level (e) in thymocyte
suspensions from Adx and sham-Adx rats (A) and from KET-
and PEG-treated Adx and orchidectomized rats (B)
Results are expressed as means ± SEM (n = 6). ∗P < 0.05, ∗∗P < 0.01.
Discussion
The present study demonstrated that lack of adrenal GCs,
as well as inhibition of local GC synthesis in the absence
of adrenal GCs, influences the thymic NA concentration
by modulating the abundance and/or synthetic capability
of distinct thymic sources of NA and influences
thymocyte and possibly thymic non-lymphoid cell AR
expression.
Effect of surgical removal of circulatory adrenal
hormones on thymic CA-containing nerve fibres and
cells and AR expression in male Dark Agouti rats
The first set of our experiments indicated that
adrenalectomy decreased thymic NA concentration by
diminishing the expression of TH and DBHmRNAs. The
decrease in TH mRNA expression was consistent with
data showing that GCs upregulate TH gene transcription
in some non-immune system cells (Lucas & Thoenen,
1977; Sabban, 1997). The decrease in the DBH mRNA
level in thymi from Adx rats was in accordance with
the finding that GCs enhance DBH mRNA expression
in PC12 cells (McMahon & Sabban, 1992). Furthermore,
it seems obvious that these changes were sufficient to
provide the reduction in the NA level, notwithstanding
the decline in the level of mRNA encoding MAO-A (a
key enzyme for the degradation of NA, dopamine and
serotonin) in thymi from Adx rats. In support of this
finding are data showing that GCs enhance MAO-A gene
expression in many cell types (Manoli et al. 2005; Ou
et al. 2006). Subsequent analyses showed that the NA
content in thymi from Adx rats was diminished in the
autofluorescent noradrenergic nerve fibres (judging by the
reduced intensity of autofluorescence) and thymocytes
(as concluded from the findings indicating changes in
the amount of NA and TH, the major regulator of
CA synthesis, per thymocyte). There are several lines
of evidence to explain the reduced fluorescence in
autofluorescent nerve fibres. Firstly, it was shown that
15 days postadrenalectomy the concentration of NA was
decreased in the rat hypothalamus (Rastogi & Singhal,
1978), which is the site of the group of neurons involved
in the regulation of thymic sympathetic nervous fibre
activity (Trotter et al. 2007) and that administration of
corticosterone to Adx rats effectively reversed the decrease
in the concentration of this neurotransmitter (Rastogi
& Singhal, 1978). Secondly, there is evidence that in
the rat superior cervical ganglion, where noradrenergic
fibres innervating the thymus originate (Tollefson &
Bulloch, 1990), preganglionicnerve stimulation elicited an
increase in TH expression and activity (Biguet et al. 1989).
Furthermore, there aredata suggesting adirect stimulatory
influence of dexamethasone on the TH synthesis in organ
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cultures of rat superior cervical ganglia (Nagaiah et al.
1977).
The decreased density of autofluorescent nerve
fibres also contributed to the decrease in NA
concentration in large thymi from Adx rats. This finding
suggested that thymic hypertrophy was not followed by
proportional growth of autofluorescent CA-containing
nerve fibres. This could be related to data showing
Figure 5. Influence of adrenal- and thymus-derived glucocorticoids on β2-adrenoceptor (AR) expression
in thymus and thymocytes
A, representative photomicrograph illustrates β2-AR-positive thymocytes (arrows) and thymic non-lymphoid cells
(arrowheads) in thymi from sham-adrenalectomized (Adx) rats. Original magnification ×400. Abbreviations: C,
cortex; and M, medulla. Dashed black line indicates the cortico-medullary border. The histograms indicate the
numerical density (Nv) of thymocytes, thymic non-lymphoid cells and all thymic cells expressing β2-AR (a), the
thymic β2-ARmRNA expression (b), the percentage of β2-AR-positive thymocytes (c), the β2-ARmean fluorescence
intensity (MFI) on β2-AR-positive thymocytes (d) and the β2-AR mRNA level (e) in thymocyte suspensions from
Adx and sham-Adx rats (B) and KET- and PEG-treated Adx and orchidectomized rats (C). Results are expressed as
means ± SEM (n = 6). ∗P < 0.05.
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that: (i) adrenalectomy decreases the level of nerve
growth factor, a potent axon growth factor for neuronal
populations in the peripheral nervous system, in adult rats
(Aloe, 1989); and (ii) rat thymic cells express nerve growth
factor (Lee et al. 2007).
We found an unaltered intensity of fluorescence of
large subcapsular and medullar autofluorescent cells,
which are most likely to represent subsets of CA-
synthesizingTECsandmacrophages (Pilipovic´ et al.2008).
Although thymic macrophages, in particular those at the
Figure 6. Influence of adrenal- and thymus-derived glucocorticoids on α1B-AR expression in thymus and
thymocytes
A, representative photomicrographs illustrating α1B-AR-positive thymocytes (arrows) and thymic
non-lymphoid cells (arrowheads) in thymi from adrenalectomized (Adx) and sham-Adx rats. Original
magnification ×400. Abbreviations: C, cortex; and M, medulla. Dashed black lines indicate cortico-
medullary borders. The histograms indicate numerical density (Nv) of thymocytes, thymic non-lymphoid
cells and all thymic cells expressing α1B-AR (a), thymic α1B-AR mRNA expression (b), the percentage of
α1B-AR-positive thymocytes (c), the α1B-AR mean fluorescence intensity (MFI) on α1B-AR+ thymocytes (d)
and the α1B-AR mRNA level (e) in thymocyte suspensions from Adx and sham-Adx rats (B) and KET- and
PEG-treated Adx and orchidectomized rats (C). Results are expressed as means ± SEM (n = 6). ∗P < 0.05,
∗∗P < 0.01.
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cortico-medullary junction, display autofluorescence due
to a significant lipofuscin content (Milic´evic´ et al. 1986),
the lack of significant difference in the intensity of
cellular autofluorescence between control thymic sections
(cryosections which were coverslipped only with non-
fluorescent immersion oil) from Adx and control rats
(data not shown) suggests that adrenalectomy did not
influence the CA content in thymic stromal cells. This
finding could be associated with the data indicating that
adrenalectomy has a differential effect on GC synthesis
in thymocytes and TECs (Qiao et al. 2009; Taves et al.
2011). Thus, adrenalectomy, acting via ACTH-dependent
mechanisms, decreases and increases GC synthesis in
thymocytes and TECs, respectively (Qiao et al. 2009; Taves
et al. 2011). It may therefore be assumed that the increased
local production of GCs by TECs was sufficient to prevent
adrenalectomy-induced changes in the expression of the
CA biosynthetic enzyme in thymic non-lymphoid cells,
and consequently in their NA synthesis and content.
This also implies a differential glucocorticoid-dependent
regulation of NA content in thymic lymphoid and non-
lymphoid cells.
In addition, we showed that adrenalectomy
downregulated β2-AR mRNA expression in thymic
tissue and, in thymocytes in particular. The diminished
β2-AR MFI on β2-AR-positive thymocytes indicated a
decrease in the receptor surface density in Adx rats. To
corroborate these findings, there are data suggesting
that GCs increase β2-AR expression in thymocytes and
lymphocytes, as well as in some other cell types (Jazayeri
& Meyer, 1988; Abraham et al. 2003). Considering that
NA augments α1B-AR expression via a β-AR-mediated
mechanism (Kavelaars, 2002), the diminished thymocyte
surface β2-AR expression, coupled with the decrease
in thymic NA level and thymocyte NA content, could
explain the diminished α1B-AR surface density and
α1B-AR mRNA level in thymocytes from Adx rats.
Considering the decrease in the thymic α1B-AR mRNA
expression in Adx rats in conjunction with the substantial
increase in Nv of α1B-AR-ir cells, the reduced amount
of α1B-AR mRNA per thymocyte with unaltered Nv
of α1B-AR-ir thymocytes and the markedly reduced
Nv of α1B-AR-ir thymocytes compared with α1B-AR-ir
non-lymphoid cells, a diminished expression of α1B-AR
mRNA in non-lymphoid cells from Adx rats may also
be supposed. The subsets of TECs, macrophages and
dendritic cells have been shown to express α1B-ARs
(Leposavic´ et al. 2011).
Effect of ketoconazole inhibition of thymic steroid
synthesis and action on thymic CA-containing nerve
fibres and cells and AR expression in Adx and
orchidectomized male Dark Agouti rats
This set of experiments showed that KET-induced
withdrawal of thymic GCs in the absence of systemic
GCs increased the thymic expression of NA biosynthetic
enzymes and NA concentration. This could be associated
with the rise in the density of CA-containing nerve
fibres and the rise in the fluorescence intensity of large
autofluorescent cells, which is most likely to reflect an
increase in their CA content. Given that thymic NA
concentrationwas increased inKET-treated rats compared
with control animals, it seems obvious that in these
animals the increase in nerve fibre density and non-
lymphoid cell NA content was more pronounced than the
decrease in the thymocyte NA content. The differential
effect of KET on CA content in thymocytes and thymic
non-lymphoid cells was consistent with the findings from
the first set of experiments. Furthermore, considering the
data from both sets of experiments it may be assumed that
thymicGCs diminish CA (NA) synthesis in TECs, which is
different from their effect in thymocytes. In favour of this
option are data showing that GCs influence the expression
of enzymes involved in CA biosynthesis and degradation
in a tissue- and cell-type-specific manner (Hiwatashi et al.
2002; Kano et al. 2005; Lindley et al. 2005; Kvetnansky
et al. 2009).
The expression of β2-AR mRNA measured in thymic
tissue and in thymocytes was not affected by inhibition of
local GC synthesis. However, the expression of α1B-AR at
both mRNA and protein levels per thymocyte and, most
probably, α1B-AR mRNA in thymic non-lymphoid cells,
was upregulated. In light of our previous data indicating
that chronic blockade of α1-ARs increases thymic weight
and cellularity (Leposavic´ et al. 2011), the increased α1B-
AR expression on thymic cells and the elevated thymic
NA level in KET-treated rats were fully consistent with
the decline in thymic weight and thymocyte number in
these rats. The increase in α1B-AR expression following
removal of the local GC synthesis in rats deprived of
adrenal GCs could be linked with the data showing that
the gene for α1B-AR contains a GC response element
within its promoter region (Gao & Kunos, 1993) and that
adrenalectomy increases α1B-adrenoceptor mRNA levels
in the rat hypothalamic paraventricular nucleus (Day et al.
1999). Alternatively, it may be ascribed to augmented
stimulation of β-ARs in thymic settings enriched with
NA (Kavelaars, 2002).
Conclusion
In conclusion, the study provided novel evidence for the
following: (i) a modulatory role of GCs in the expression
of genes encoding enzymes involved in CA synthesis
and metabolism and AR synthesis; (ii) thymic cell-type-
specific GC regulation of the mRNA expression of CA
synthetic and degrading enzymes; and (iii) local GC
synthesis in the thymus. It also indicates a putative role
of local GCs in modulation of thymic CA synthesis
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and bioavailability and AR expression. Therefore, CAs
may be viewed as mediators in GC-mediated tuning of
thymopoiesis and, consequently, the T-cell compartment,
suggesting that pharmacological modulation of CA action
may modulate GC-dependent effects. The data on the
differential effects of β-AR blockade in Adx and non-
Adx rats support this concept. This may be particularly
important when homeostasis is disturbed by various
stressors or in the state of adrenal insufficiency.
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Figure S1. Influence of adrenal- and thymic-derived
glucocorticoids on noradrenaline (NA) level in (a)
thymi and (b) thymocyte suspensions of (Panel A)
adrenalectomised (Adx) and sham-Adx rats and (panel B)
Ketoconazole- (KET) and polyethylene glycol-
administered (PEG) Adx and orchidectomised rats.
Arrows indicate peaks corresponding to NA.
Figure S2. Influence of adrenal- and thymic-derived
glucocorticoids on thymocyte expression of (a) tyrosine
hydroxylase (TH), (b) β2-adrenoceptor (AR) and (c) α1B-
AR in (Panel A) adrenalectomised (Adx) and sham-Adx
rats and (panel B) Ketoconazole- (KET) and polyethylene
glycol-administered (PEG) Adx and orchidectomised rats,
as determined by flow cytometry analysis.
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